Previous close | 2.6000 |
Open | 2.6000 |
Bid | 2.0000 |
Ask | 4.2000 |
Strike | 35.00 |
Expiry date | 2025-01-17 |
Day's range | 2.6000 - 2.6000 |
Contract range | N/A |
Volume | |
Open interest | 12 |
Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.
The Alzheimer's treatment space is heating up — and could soon leave Eli Lilly's embattled drug, donanemab, in the dust, experts say.